Modeled speed geometry for sildenafil is a PK→PD construct describing how absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, and dose-scaling geometry shape rising-phase and peak trajectories. In this framework, speed refers only to modeled PK→PD curve behavior and does not represent real-world timing. Absorption rate influences rising-phase steepness, while absorption timing determines temporal alignment of the input profile. Solubility contributes to dissolution-driven availability, and gastric emptying modifies modeled input arrival. Distribution loading defines early compartment representation, distribution geometry describes movement between modeled spaces, and clearance geometry influences concentration removal. Dose-scaling geometry determines how 25 mg, 50 mg, and 100 mg inputs are represented relative to one another. PD interpretation then transforms PK trajectories through threshold placement, binding sensitivity, coupling geometry, and PD noise bands to create modeled speed coordinates. Link to speed overview.
Modeled duration geometry for sildenafil describes the tail-phase structure of a concentration-time trajectory within a PK→PD model. Duration geometry refers strictly to mathematical persistence characteristics of the simulated curve and not to real-world duration. Clearance geometry determines the shape of the declining phase, while redistribution timing influences secondary trajectory transitions. Distribution geometry defines movement across modeled compartments, and concentration-dependent clearance can modify curvature throughout the tail region. Dose-scaling geometry influences how tail-phase structure differs between modeled input levels. Early-phase parameters including solubility, gastric emptying, and absorption timing establish initial curve conditions that influence later trajectory behavior. Under duration modeling, PK geometry generates the concentration profile that PD parameters transform through additional interpretation layers. These relationships describe parameter-driven curve structures within a mechanistic framework only. Link to elimination speed.
PD geometry shapes modeled speed versus duration differences by transforming sildenafil PK trajectories into mathematical interpretation coordinates. Threshold placement determines where the concentration curve intersects a modeled PD boundary. Binding sensitivity controls how concentration differences are converted into modeled binding differences; higher modeled sensitivity can expand separation between trajectories, while lower sensitivity can compress differences. Coupling geometry determines how binding relationships are represented through downstream mathematical signals, with shallow slopes broadening transitions and steep slopes compressing them. PD noise bands create interpretation ranges around calculated coordinates. Because sildenafil can be represented through different PK parameter combinations involving absorption rate, solubility, gastric emptying, distribution loading, distribution geometry, clearance geometry, Tmax geometry, and Cmax geometry, PD mapping can expand or compress modeled speed and duration differences. Link to pk speed.
PK geometry defines the concentration trajectories used for sildenafil speed versus duration modeling. Absorption rate controls the modeled slope of the rising phase, while absorption timing determines temporal positioning of the input curve. Solubility contributes to dissolution-driven availability, and gastric emptying modifies modeled input arrival. Distribution loading represents early compartment concentration placement, while distribution geometry describes movement between modeled spaces. Redistribution timing influences later trajectory phases. Clearance geometry, first-pass metabolism, and bioavailability determine concentration removal and persistence characteristics. Dose-scaling geometry defines how different modeled inputs generate distinct curve structures. Tmax geometry identifies the location of modeled peak coordinates, while Cmax geometry defines peak amplitude characteristics. Concentration-dependent clearance can alter the shape of both rising and tail-phase regions. Together, these PK parameters generate the trajectories later transformed by PD interpretation layers. Link to absorption rate.
PK variability produces different modeled speed and duration windows by changing the mathematical structure of sildenafil concentration trajectories. Variations in absorption rate, absorption window width, gastric emptying, solubility, distribution loading, redistribution timing, metabolism geometry, elimination geometry, and bioavailability alter the simulated curve. Tmax geometry and Cmax geometry modify peak-related features, while clearance geometry influences the tail-phase structure. Dose-scaling geometry determines how different modeled input levels are represented within the same framework. These PK differences are subsequently processed through PD parameters including threshold placement, binding sensitivity, coupling geometry, and noise bands. The resulting speed and duration geometry represents interactions between model variables only and does not describe observed timing, real-world duration, or individual response patterns. Link to distribution speed.
| PK Domain | Speed vs Duration Interaction | Link |
|---|---|---|
| Absorption Rate | Steeper or flatter rising phase. | absorption rate |
| Distribution Geometry | Compartmental spread. | distribution speed |
| Clearance | Tail-phase geometry. | elimination speed |
PD interpretation transforms sildenafil PK trajectories into modeled speed and duration coordinates through mathematical response mapping. Threshold placement determines the concentration boundary used for assigning a modeled transition location. Binding sensitivity defines how concentration variation becomes modeled binding variation. Coupling geometry controls the relationship between binding variables and downstream signal representation. PD noise bands establish ranges around calculated coordinates. These parameters operate after PK trajectory generation and modify how the curve is interpreted within the model. Changes in threshold location, sensitivity values, coupling slopes, or noise widths can alter the shape of modeled speed and duration geometry. These effects represent mathematical transformation behavior only. Link to pd speed.
Binding sensitivity, coupling geometry, and PD noise bands determine whether modeled speed versus duration differences appear compressed or expanded. Higher sensitivity parameters can increase separation between simulated PK trajectories, while lower sensitivity parameters can reduce visible differences. Coupling geometry shapes downstream transformation curves through slope and curvature changes. Noise bands adjust interpretation regions around modeled coordinates. Combined with PK variables such as absorption rate, Tmax geometry, Cmax geometry, distribution geometry, and clearance geometry, these PD modifiers create a complete PK→PD mapping structure. The resulting geometry explains how model parameters interact to generate simulated speed and duration relationships without extending interpretation into real-world effectiveness, timing, or outcomes. Link to pk speed.
| PD Domain | Speed vs Duration Effect | Link |
|---|---|---|
| Threshold Placement | Earlier/later PD coordinate. | onset time |
| Binding Sensitivity | Amplification/compression. | onset variability comparison |
| Coupling Geometry | Slope-driven shaping. | peak variability comparison |
Modeled speed versus duration differences are determined by interactions between PK trajectory parameters and PD transformation parameters. PK factors include absorption rate, absorption timing, solubility, gastric emptying, absorption window width, distribution loading, distribution geometry, redistribution timing, clearance geometry, first-pass metabolism, bioavailability, dose-scaling geometry, Tmax geometry, Cmax geometry, and concentration-dependent clearance. These variables define the simulated concentration curve. PD factors including threshold placement, binding sensitivity, coupling geometry, and noise bands then transform that curve into modeled speed and duration coordinates. Differences between trajectories represent parameter-driven variation within a PK→PD model. They do not represent observed onset timing, duration timing, clinical outcomes, or individual biological responses.
PK mechanisms shaping speed versus duration geometry include processes controlling concentration entry, distribution, and removal. Absorption rate affects the modeled rising phase, while absorption timing determines input alignment. Solubility and gastric emptying influence the structure of the absorption profile. Distribution loading and distribution geometry define compartmental movement. Redistribution timing affects later trajectory phases. Clearance geometry, first-pass metabolism, and bioavailability influence concentration persistence and removal. Dose-scaling geometry determines how different inputs are represented. Tmax and Cmax geometry describe peak-related curve features. These mechanisms explain mathematical PK behavior within the model and do not describe real-world speed, duration, or timing characteristics.
PD mechanisms shape speed versus duration interpretation by transforming PK concentration curves into modeled coordinates. Threshold placement determines the concentration boundary used for assigning transitions. Binding sensitivity controls how concentration changes are translated into modeled binding differences. Coupling geometry defines how these relationships propagate through downstream signal structures. PD noise bands introduce ranges around calculated coordinates. Together, these parameters determine how differences between PK trajectories appear within the simulation. PD interpretation occurs after PK trajectory creation and modifies mathematical representation. These mechanisms describe model behavior only and do not represent clinical measurements, effectiveness assessments, or individual outcomes.
Modeled speed versus duration trajectories differ because PK→PD simulations can use different combinations of input parameters. Changes in absorption rate, absorption timing, solubility, gastric emptying, absorption window width, distribution loading, distribution geometry, redistribution timing, clearance geometry, bioavailability, first-pass metabolism, and dose-scaling assumptions modify the concentration trajectory. Tmax geometry and Cmax geometry may also shift when parameter structures change. PD variables including threshold placement, binding sensitivity, coupling geometry, and noise bands further modify interpretation. These differences describe mathematical sensitivity within a model and do not indicate observed timing patterns, real-world duration, or individual biological behavior.
PK→PD mapping explains modeled speed versus duration differences by connecting concentration trajectory generation with PD transformation rules. The PK layer creates curves using absorption, distribution, metabolism, elimination, dose-scaling, Tmax, and Cmax parameters. The PD layer applies thresholds, binding sensitivity, coupling relationships, and noise ranges to transform those curves into modeled coordinates. Changes in PK parameters modify the input trajectory, while changes in PD parameters modify interpretation of that trajectory. The resulting speed and duration geometry reflects interactions between both model layers. This framework describes simulated parameter relationships only and does not represent measured timing, effectiveness, safety, or individual response characteristics.